APT Medical Inc. (SHA: 688617)

Market Cap	35.39B
Revenue (ttm)	1.96B
Net Income (ttm)	658.82M
Shares Out	96.94M
EPS (ttm)	6.76
PE Ratio	53.98
Forward PE	50.62
Dividend	1.38 (0.39%)
Ex-Dividend Date	Jul 26, 2024

Volume	854,554
Open	337.93
Previous Close	337.02
Day's Range	337.08 - 351.53
52-Week Range	213.81 - 480.00
Beta	-0.41
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About APT Medical

APT Medical Inc. engages in the research, development, manufacturing, and supply of electrophysiology and vascular interventional medical devices in China. The company offers electrophysiological products comprising mapping catheters, ablation catheters, transseptal needle and sheaths, and steerable sheaths; and interventional cardiology and peripheral intervention products, such as introducer kits, guiding extension catheters, balloon catheters, guiding catheters, microcatheters, guidewires, hydrophilic angiographic catheters, hydrophilic guid...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 2,155
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688617

Financial Performance

In 2023, APT Medical's revenue was 1.65 billion, an increase of 35.71% compared to the previous year's 1.22 billion. Earnings were 533.92 million, an increase of 49.13%.